VEEA · XBRL financial data
Veea financial statements, every fiscal year
The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (VEEA's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | 9,072 | 142 | 222 |
| Cost of goods and services sold | — | — | 467 | 83 | 70 |
| Gross profit | — | — | 8,605 | 58 | 152 |
| Research and development | — | — | 693 | 1,373 | 328 |
| General and administrative | — | — | 17,238 | 26,639 | 17,652 |
| Total operating expenses | — | — | 18,965 | 84,136 | 18,987 |
| Operating income (loss) | (2,917) | (4,074) | (3,098) | (84,078) | (18,835) |
| Interest income | 16 | 4,679 | 4,759 | — | — |
| Interest expense | — | — | 5,319 | 1,808 | 2,202 |
| Income tax expense (benefit) | — | — | 74 | 15 | 1 |
| Net income (loss) | 6,594 | 10,578 | (35) | (47,548) | (6,660) |
| Earnings per share, basic USD per share | — | — | (0.97) | (1.88) | (0.16) |
| Earnings per share, diluted USD per share | — | — | (0.97) | (1.88) | (0.16) |
| Weighted average shares, basic thousands of shares | — | — | 16,155 | 25,257 | 42,806 |
| Weighted average shares, diluted thousands of shares | — | — | 16,155 | 25,257 | 42,806 |
Balance sheet
CSVFiscal years (VEEA's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 107 | 86 | 95 | 1,686 | 134 |
| Inventory | — | — | 7,376 | 7,459 | 9,654 |
| Prepaid and other current assets | — | — | 514 | 5,650 | 5,638 |
| Total current assets | 451 | 130 | 146 | 14,879 | 15,566 |
| Property and equipment, net | — | — | 377 | 211 | 92 |
| Right-of-use asset | — | — | 545 | 117 | — |
| Goodwill | — | 4,577 | 4,797 | 4,780 | 5,102 |
| Total assets | 319,732 | 324,042 | 35,702 | 21,094 | 28,221 |
| Accounts payable | — | — | 1,078 | 1,291 | 4,054 |
| Accrued liabilities | — | — | 4,741 | 5,569 | 1,531 |
| Total current liabilities | 1,171 | 3,876 | 7,736 | 20,136 | 31,818 |
| Lease liability, non-current | — | — | 119 | — | — |
| Total liabilities | 21,696 | 15,428 | 9,379 | 38,119 | 37,973 |
| Accumulated deficit | (21,181) | (15,298) | (15,333) | (217,831) | (224,491) |
| Total stockholders' equity | (21,180) | (15,298) | (9,234) | (17,025) | (9,752) |
| Total liabilities and equity | 319,732 | 324,042 | 35,702 | 21,094 | 28,221 |
| Common shares outstanding (cover page) thousands of shares | — | — | 19,636 | 36,440 | 50,408 |
Cash flows
CSVFiscal years (VEEA's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Net income (loss) | 6,594 | 10,578 | (35) | (47,548) | (6,660) |
| Stock-based compensation | — | — | 485 | 6,699 | 1,136 |
| Depreciation and amortization | — | — | — | 274 | 632 |
| Net cash from operating activities | (2,138) | (1,021) | (1,063) | (25,595) | (15,228) |
| Purchases of property and equipment | — | — | 35 | 46 | 8 |
| Net cash from investing activities | (319,216) | 0 | 293,115 | (265) | (247) |
| Proceeds from issuing common stock | 312,832 | 0 | 1,961 | 9,961 | 5,289 |
| Share repurchases | — | — | 294,255 | — | — |
| Net cash from financing activities | 321,462 | 1,000 | (292,044) | 21,573 | 13,937 |
| Net change in cash | 107 | (21) | 5,824 | (4,324) | (1,552) |
Compare with peers
SIC 7373 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 7373 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Veea | 1,942 | 176 | (5,932)* | 62.2M | 0.3 quarters | 10-QJun 30, 2026 |
| Healthcare Triangle | 1,906 | 9,193 | (833)* | 15.0M | 2.3 quarters | 10-QJun 30, 2026 |
| RideNow Group | 46,700 | 296,800 | (100)* | not reported | 467.0 quarters | 10-QJun 30, 2026 |
| Nixxy | 330 | 16,091 | (982)* | 28.9M | 1.8 quarters | 10-QJun 30, 2026 |
| Cloudastructure | 3,807 | 1,233 | (1,946)* | not reported | 2.0 quarters | 10-QJun 30, 2026 |
| Airwa | 11,085 | 21,244 | 27,672 | 4.6M | — | 10-QJul 31, 2026 |
| Avai Bio | 84 | not reported | (414) | 153.9M | 0.2 quarters | 10-QJun 30, 2026 |
| BioScience Health Innovations | 712 | 1,036 | (542)* | 11.8M | 1.3 quarters | 10-QJun 30, 2026 |
| Golden Matrix Group | 17,319 | 50,194 | 7,799* | 12.7M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.